Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • TROP2
    (2)
  • ADC Antibody
    (1)
  • Antibody-Drug Conjugates (ADCs)
    (1)
TargetMol | Tags By Application
  • ELISA
    (3)
  • FCM
    (3)
  • Functional assay
    (3)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
Filter
Search Result
Results for "

sacituzumab govitecan

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    3
    TargetMol | Inhibitory_Antibodies
  • ADC/ADC Related
    1
    TargetMol | All_Pathways
  • Sacituzumab govitecan
    IMMU-132
    T778241491917-83-9
    Sacituzumab govitecan (IMMU-132) is a humanized ADC compound targeting Trop-2 with anticancer activity for the study of refractory, locally advanced or metastatic breast cancer and uroepithelial cancer.
    • $455
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
  • Sacituzumab
    Sacituzumab (anti-Trop-2), Sacituzumab
    T353971796566-95-4
    Sacituzumab (hRS7) is an antibody inhibitor and a humanized monoclonal antibody targeting trophoblast cell surface antigen 2 (TROP2), serving as a component of the antibody-drug conjugate sacituzumab govitecan, used for research and treatment of TROP2-high-expressing tumors such as triple-negative breast cancer.
    • $163
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
  • Sacituzumab (Powder)
    Sacituzumab, 1796566-95-4
    T35397P
    Sacituzumab (Powder) is an antibody inhibitor and a humanized monoclonal antibody targeting trophoblast cell surface antigen 2 (TROP2), serving as a component of the antibody-drug conjugate sacituzumab govitecan, used for research and treatment of TROP2-high-expressing tumors such as triple-negative breast cancer.
    • $179
    2 weeks
    Size
    QTY